000 01443 a2200397 4500
005 20250517235713.0
264 0 _c20181217
008 201812s 0 0 eng d
022 _a2041-1723
024 7 _a10.1038/s41467-018-05984-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStevens, Brett M
245 0 0 _aCharacterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.
_h[electronic resource]
260 _bNature communications
_c09 2018
300 _a3694 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Transformation, Neoplastic
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aFlow Cytometry
650 0 4 _aHematopoietic Stem Cells
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInterleukin-3 Receptor alpha Subunit
_xmetabolism
650 0 4 _aLeukemia, Myeloid, Acute
_xmetabolism
650 0 4 _aMyelodysplastic Syndromes
_xmetabolism
650 0 4 _aOxidative Phosphorylation
700 1 _aKhan, Nabilah
700 1 _aD'Alessandro, Angelo
700 1 _aNemkov, Travis
700 1 _aWinters, Amanda
700 1 _aJones, Courtney L
700 1 _aZhang, Wei
700 1 _aPollyea, Daniel A
700 1 _aJordan, Craig T
773 0 _tNature communications
_gvol. 9
_gno. 1
_gp. 3694
856 4 0 _uhttps://doi.org/10.1038/s41467-018-05984-x
_zAvailable from publisher's website
999 _c28829675
_d28829675